The affibody tracer ABY-029, directed toward EGFR and conjugated site-specifically with IRDye800CW via a C-terminal cysteine, is currently undergoing clinical translation for FIGS in glioma, head and neck cancer and soft tissue sarcoma. The gene discussed is EGFR; the disease is glioma.